AvKARE Updates Prescribing Information for Etonogestrel and Ethinyl Estradiol Vaginal Ring

AvKARE has released updated prescribing information for the etonogestrel and ethinyl estradiol vaginal ring, a hormonal contraceptive device. The updated documentation, published on September 11, 2026, outlines the clinical specifications, usage instructions, and safety profile for the product as registered in the DailyMed database.

The updated filing details the pharmacological composition of the ring, which releases a combination of the progestin etonogestrel and the estrogen ethinyl estradiol to prevent pregnancy. The documentation provides comprehensive guidance on the insertion and removal process, the recommended duration of use, and the management of potential side effects. It also includes clinical data regarding contraindications, drug interactions, and warnings for patients with specific medical histories. Healthcare providers and patients can access the full technical specifications and regulatory information through the National Library of Medicine’s DailyMed portal.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: September 11, 2026

Author

GOAI